tiprankstipranks
The Fly

CSL initiated with a Buy at Goldman Sachs

CSL initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Davin Thillainathan initiated coverage of CSL (CSLLY) with a Buy rating and A$325.40 price target The firm believes the company’s investments in its immunoglobulin franchise and new product launches in the Behring portfolio are set to increase return on invested capital.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1